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Diffusion-weighted imaging outside the brain: consensus statement from an 





The significant advances in MRI hardware and software, sequence design, and post-
processing methods have made diffusion-weighted imaging (DWI) an important part of 
body MRI protocols and have fueled extensive research on quantitative diffusion outside 
the brain, particularly in the oncologic setting. In this review, we summarize most up-to-
date information on DWI acquisition and clinical applications outside the brain, as 
discussed in an ISMRM sponsored symposium held in April 2015. We first introduce 
recent advances in acquisition, processing, and quality control; then review scientific 
evidence in major organ systems; and finally describe future directions.   
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1. Introduction 
Extra-cranial diffusion-weighted imaging (DWI) is now widely applied in clinical practice 
to enhance disease assessment, particularly in the oncological setting. A National 
Cancer Institute (NCI) sponsored open consensus meeting was held in 2008 in Toronto 
during the ISMRM meeting, which led to the publication of a consensus and 
recommendation paper in 2009 (1). Since then, the field of body DWI has seen rapid 
expansion in both research and clinical applications. In 2015, an ISMRM sponsored 
meeting was held from the 1st to 3rd April in Boston, which aimed to survey the current 
state-of-the-art knowledge and developments in extra-cranial DWI. This paper 
summarizes the discussions and consensus opinions at that meeting, and provides a 
broad review and update of developments in the field.  
 
2. Recent technological advances in DWI acquisition  
DWI is increasingly finding powerful applications outside the brain, where it was first 
used. This migration has been enabled by several factors, including technological 
advances, pulse sequence development and new data analysis frameworks.  
DWI in clinical scanners is generally performed with single-shot k-space 
trajectories, most commonly the echo-planar imaging (EPI), and analysis is performed 
on the magnitude channel, discarding the phase information. Single-shot EPI collects a 
series of gradient echoes to fill in the required k-space raster. Since the resulting echo 
train occurs over a finite time interval, they suffer (a) phase shifts and (b) signal 
attenuation from variations in the local applied magnetic field. These effects can be 
reduced by shortening the echo train length (ETL), by increasing receiver bandwidth or 
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using undersampling from partial Fourier reconstruction (2), multiple receiver coil 
parallel imaging (3), or both. Higher gradient systems have thus shortened readouts and 
improved EPI DWI. Higher field strength systems present competing influences for DWI 
(higher SNR vs. shorter relaxation times, etc.) but eventually successful compromises 
have been achieved. For example, RF field (B1) inhomogeneity at higher field can be 
particularly pronounced for large abdominal fields of view (FOV), but the rise in 
prevalence of receiver array coils allowed a reversal of this disadvantage by enabling 
better parallel imaging performance. Image-based shimming (4) has also been applied 
to emphasize the image quality of target areas within a large FOV. Similarly, transmit 
fields have been controlled to a higher degree to benefit DWI. Given the large fields of 
view and image matrices for body imaging, an increasingly prevalent approach is to limit 
the imaged volume to a target zone (reduced field of view, rFOV) (Fig. 1) either by inner 
volume imaging (IVI) or outer volume suppression (OVS). This approach has found 
application in, thyroid (5), pancreas (6), kidney (7), breast (8, 9), and spinal cord (10) 
DWI. Multiple excitation body coils, making selective excitation via shaped RF pulses 
more feasible with shorter pulse durations in the context of parallel transmission, have 
been demonstrated (11). 
Multi-shot DW EPI sequences using 2D navigators have been successfully 
applied in the brain, although more severe motions limit use in the abdomen. Alternative 
to EPI readout, a train of RF pulses in TSE/FSE sequences ‘undo’ phase evolution 
thereby effectively removing spatial distortion. While TSE/FSE is extremely robust and 
widely used for traditional imaging, insertion of DW gradient pulses in a TSE/FSE 
sequence makes the phase of transverse magnetization ill-defined relative to RF-pulse 
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phase. This can lead to substantial artifact in multi-shot DW TSE/FSE. Fortunately, 
phase-cycling RF pulses stabilizes echo signal amplitude relative to arbitrary initial 
transverse magnetization phase thus greatly reduces these artifacts. Strategies to parse 
k-space and incorporate navigator information are varied and include periodically 
rotated overlapping parallel lines (PROPELLER) via short or long readouts (12), split-
echo propeller (SPLICE) and self-navigated interleaved spirals (SNAILS) (13-15). The 
trade-off between low distortion vs. motion artifact immunity for applications such as 
lesion detection and ADC quantification are being studied. Commercialized versions of 
these non EPI-based and multi-shot techniques are now available and look particularly 
promising in less kinetic organs such as breast and prostate (16-18). 
For a successful multi-b value DWI experiment, it is important to optimize SNR at each 
b-value. The number of signal averages is usually increased for higher b values so that 
a DWI with multiple b-values experiment can be performed at an acceptable SNR in 
clinically reasonable times.   
Another less commonly tuned encoding parameter is the diffusion time. To put it in 
context, the confinement length scales of extracranial organs often differs from those 
prevalent in cerebral tissue (~1-10 µm) and DTI (diffusion tensor imaging) metrics are 
correspondingly different. A useful guide to the diffusion sensitivity is the ratio of the 
diffusion length  to the confinement length scale. When the primary cell size 
(tubule, myofiber, duct) is larger in scale than cerebral axons, diffusivities are larger and 
anisotropies are smaller. This drop in contrast can be ameliorated by increasing the 
diffusion time, which is most conveniently done with a stimulated echo preparation (19-
2Dt
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21). When properly included, this not only increases contrast but detailed tissue 
modeling can also be achieved at longer diffusion times (22, 23). 
In summary, advances in hardware, pulse sequence variations, and generalized 
analysis have spurred tremendous recent progress in DWI outside the brain. The result 
is no longer a direct transposition of DWI methods from the brain but an adaptation 
specific to the challenges and opportunities of extracranial anatomies. 
 
3. Diffusion measurement reproducibility and precision assessment  
“Repeatability” and “reproducibility” are often used to empirically assess (in)consistency 
of quantitative measures. In terms of ADC, repeatability relates to the consistency of 
ADC values when the same imaging test of the same object (patient) is performed at 
short intervals on the same scanner by the same operator; whereas, reproducibility is 
the consist ncy of ADC values when the same imaging test (or as close as possible) of 
the same object is performed on different equipment, typically by different operators at 
different centers.  
3.1 Sources of variance 
Performing an ADC estimate spans multiple domains that independently contribute to 
variance: (a) biological (patient size/shape/cooperativeness/lesion location & 
heterogeneity/phenotype; potential therapeutic effects); (b) scan operator (protocol 
build, patient set-up, skill level); (c) MRI system (hardware/software platform; DWI 
sequence and acquisition parameters; and individual scanner idiosyncrasies); (d) 
algorithm to convert DWI to ADC; and (e) radiologist/analyst definition of measurement 
region. 
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3.2 Technical variance 
The MRI system itself and platform capabilities are the heart of technical variance.  
Cross-vendor/platform capabilities also lead to protocol variance. While high level 
parameters (e.g. geometry and b-values) can usually be matched, secondary 
parameters (DWI waveform design, echo-spacing, shim and fat-suppression technique, 
etc.) are often difficult to replicate across platforms. Unfortunately, what is the optimal 
protocol on one platform may not be optimal on another. Physical phantoms offer the 
best means to assess technical performance. A variety of ADC phantom designs have 
been proposed (24, 25). Ice water-based phantoms are popular for multi-center trials 
since they are inexpensive and provide an absolute truth diffusion coefficient since the 
media temperature is controlled that would otherwise add large uncertainty (>10%) in 
ADC values. In one phantom study across 35 multi-vendor/field-strength/site MRI 
systems, intra-exam stability of ice-water ADC measured at magnet isocenter was ~1% 
(2SD/Mean). Longer-term repeatability and cross-system reproducibility (34 systems 
excluding one outlier) were comparable at ~4% (2SD/Mean) at isocenter (26), though 
increased systematically for off-center ADC (27), with mean ADC bias estimated in vitro 
at -20% (±20%, superior-inferior) and +7% (±15%, right-left) for measurements away 
from isocenter (27). The ~4% reproducibility represents a technical baseline level to 
which other sources (biology, analysis methods) will add. Note that repeatability and 
inter-platform reproducibility in vivo will not be as good as the one for phantoms, due to 
added complexity during acquisition (motion, cardiac and pulsation artifacts, shimming, 
fat suppression, etc). System performance metrics used for site certification and 
periodic QC (quality control) in multi-center trials include: ADC bias from known value; 
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spatial variation in ADC; intra-exam ADC stability; DWI SNR; and acquisition protocol 
compliance. 
3.3 Repeatability and reproducibility of ADC in tissues 
Since diffusion measurement is completely non-invasive, it can be repeated within a 
single exam, which is certainly more convenient to patients. Rather than merely acquire 
two DWI series in immediate succession, the “coffee break” method offers some 
resemblance to the preferred repeated measures experiment, which spans multiple 
scan dates. Intra-vendor and inter-vendor variance of brain ADC was studied using 12 
human phantoms each scanned at different institutions, as well as repeated scans on 
two human phantoms on each system (28). Intraindividual differences from repeated 
scans on the same system were 2.5-5.4%, whereas the average inter-vendor 
differences ranged from 3.8-8.8%. For normal tissues in the abdomen, a short-term and 
long-term r peatability study on one 3T scanner revealed a 14% coefficient of variation 
(CV=SD/mean) (29). These results were similar to another abdominal study that also 
compared various acquisition techniques (30). In abdominal tumors, a two-site 
reproducibility study in 16 patients revealed a 14% coefficient of repeatability 
(2SD/Mean) for ADC calculated from b-value range 0-750, but much higher value (less 
consistent) using low b-values 0-100 (31). Another recent study in hepatocellular 
carcinoma (HCC) reported poor reproducibility of IVIM parameters D* and PF/f with CVs 
of 60.6% and 37.3%, while D/ADC had much better reproducibility (CV 19.7% and 
<16%) (32).  
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4. Diffusion quantification beyond ADC  
For nearly 30 years the ADC has been employed to describe water diffusion within 
biological tissues. The term apparent diffusion was used at the outset of clinical DWI in 
recognition that biological tissues are heterogeneous and contain multiple interacting 
compartments. These interactions include among others, water exchange and blood 
flow, and these properties will result in non-Gaussian diffusion. However, early diffusion 
measurement protocols using only 2 b-values [until recently of modest magnitude 
(<1000 s/mm2)] limited the analysis of diffusion data to the simplest model possible that 
of Gaussian diffusion described by a mono-exponential model from which the ADC is 
estimated (33). Modern clinical MR scanners benefit from multiple technical 
advancements in radiofrequency and gradient hardware which have resulted in 
significant improvements in DWI and there is now the opportunity to employ protocols 
using multiple b-values including b-values exceeding 2000 s/mm2 in the body. Using 
multiple b-values, particularly b-values in the range 0-200 s/mm2, sensitizes the 
diffusion measurement to capillary perfusion and other flow phenomena (34).  
4.1 Intravoxel incoherent motion (IVIM) DWI 
IVIM DWI models the diffusion-attenuated MRI signal as a sum of a static tissue 
molecular diffusion (D: diffusion coefficient, also reported as Dt: true diffusion 
coefficient, in mm2/s) and perfusion related pseudo diffusion: perfusion fraction (PF or f, 
which reflects the fraction of flowing blood, in %) and pseudo-diffusion coefficient (D*, 
which reflects the velocity of capillary blood, in mm2/s) (34-36) (Fig. 2). A free breathing 
or respiratory-triggered fat suppressed SS EPI sequence is suggested using a minimum 
number of b values. Optimal b-value selection for IVIM is more complex than for ADC 
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measurement because there are three parameters related to (in principle) independent 
tissue properties. There is no clear consensus regarding the optimal number of b values 
to be used. Recent IVIM studies have used distributions of 5 to 16 b-values that sample 
both perfusion (≤ 100 s/mm2) and diffusion (> 100 s/mm2) regimes (37-44). Because 
more b-value samples involve longer scan time, there is a need to use the smallest 
possible number of b-values where possible, for example down to 4 b values in the liver 
(0, 15, 150 and 800 s/mm2) (42). An added complexity is that b-value selection is also 
impacted by other properties of the imaging sequence, for example the flow sensitivity 
of the gradient profile, and also on the scanner manufacturer and the accuracy of the b-
value calculation. DWI data can be analyzed using least square method or Bayesian 
method. Where IVIM measurements are related to a flow phenomena the potential for 
directionally oriented flow should be considered. This has been reported in the kidney 
(45) where the anisotropy was observed for the pseudo-diffusion coefficient in the 
medulla, and in muscle (20) where a reformulation of the IVIM model in terms of 
“partially” incoherent motion was proposed. 
Repeatability studies show that IVIM estimation variability in the body may be within 
acceptable limits for PF or f, but estimates of the pseudo-diffusion coefficient D* are 
subject to much larger variations (42, 44, 46-48). In some applications, PF/f alone is 
diagnostic, and in such cases current acquisition and parameter estimation methods will 
be adequate. However, obtaining reliable D* estimates would increase the scope of 
IVIM examinations due to the potential link between D* and perfusion or other transport 
effects. Whilst most published repeatability studies focus on estimates from small 
regions or whole organs, for the approach to be useful in general, reliable voxel-wise 
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estimation is important so that parameter maps may be computed for radiological 
assessment. The variability reported for regions or organs under-estimate the errors 
with voxel-wise estimation.   
4.2 Diffusion kurtosis imaging (DKI) 
At higher b-values (>1000 s/mm2) the signal contribution of water from the extra-cellular 
space is substantially reduced, making the diffusion measurement more sensitive to 
restrictive compartments such as the intracellular compartment (49-51). The DKI model 
is an advanced mathematical fitting scheme that requires ultra high b-values, typically of 
approximately 2,000 s/mm2, and provides both a diffusion coefficient Dapp that is 
corrected to account for such non-Gaussian behavior as well as an additional metric, 
the apparent kurtosis Kapp, reflecting the extent of the non-Gaussianity.  These 
coefficients are computed using the following equation: 








 ∗).  Kapp close to 0 indicates essentially Gaussian 
diffusion and is anticipated for b-values less than approximately 1,000 s/mm2 at which 
the mono-exponential fit generally still applies. Greater Kapp reflects deviation of the 
tissue’s signal decay from the mono-exponential fit as a result of non-Gaussian diffusion 
behavior and generally is observed to a greater extent as the b-value increases beyond 
approximately 1,000 s/mm2. The DKI model has been suggested to better reflect 
microstructural heterogeneity and complexity of tissue, potentially related to the 
intracellular environment.  
4.3 Stretched-exponential model 
The use of alternative non-Gaussian diffusion models includes a stretched-exponential 
model (52, 53). This diffusion model contains a single additional stretching term, which 
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can be linked to either non-Gaussian diffusion processes or heterogeneity of Gaussian 
diffusion processes within each voxel. The model has the advantage of describing both 
Gaussian and non-Gaussian processes depending on the value of the stretching term. 
The stretching parameter has been shown to be a useful index of regional heterogeneity 
in glioma and importantly was shown to be independent of applied gradient direction. 
This model has found broad application over a wide range of b-values and clinical 
settings (54, 55). Since water molecules diffuse in the order of a few micrometers during 
the course of a typical diffusion measurement and image voxels are in the order of a 
few mm, the diffusion measurement must represent the statistical properties of a 
distribution of underlying diffusion coefficients which may or may not be Gaussian 
processes. A direct approach is therefore to model the signal attenuation as a 
continuous distribution of diffusion coefficients and estimate statistics of the underlying 
distribution, as was done using a truncated Gaussian distribution (56). An alternative 
approach uses an effective medium theory to express the diffusion signal in terms of 
higher-order moments of the diffusion propagator, which results in the DKI model. 
Given the number of diffusion models available, it is necessary to evaluate which 
model best describes the data assuming the data supports such a model. Any given 
model will require more samples (acquisitions at a given b-value) than the number of 
free model parameters. Although in principle we can hypothesize a biological basis for 
choosing to employ a particular diffusion measurement protocol and model, this should 
be confirmed by testing goodness of fit for a number of diffusion models. A further 
consideration relating to the employment of diffusion models is to determine if they are 
robust. It is well known that increasing the number of model parameters may improve 
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the overall model fit but this may be at the expense of poor measurement repeatability 
and result in correlations between model parameters.  
 
5. Current scientific evidence outside the brain 
5.1. Liver DWI  
Liver DWI acquisition technique: Fat suppressed SS EPI technique is the most 
frequently used sequence in the liver. Most DWI studies have been conducted at 1.5T, 
although there are increasing reports using 3.0T, due to increased availability and 
higher SNR. DWI of the liver is usually performed prior to contrast material 
administration, although performing DWI after the administration of gadolinium based 
contrast agents (such as gadoxetic acid) does not significantly affect ADC values (57, 
58). The shortest possible TE is suggested, as well as the use of parallel imaging to 
improve SNR and decrease distortion. DWI may be performed in breath-hold (BH) or in 
free breathing (FB) mode with multiple signal-averaging to reduce the effects of motion 
or using a respiratory-triggered (RT) acquisition (59). The choice of FB vs. RT 
acquisition is still debated for liver DWI, in terms of image quality and parameter 
reproducibility. The choice depends on time and equipment availability. For the purpose 
of ADC quantification, it is generally recommended to acquire FB or RT data, so that 
multiple b values can be acquired (acquisition time between 2-6 min).    
Choice of b values: b values used for liver imaging are typically lower than 1000 s/mm2. 
Applying a low b value <100 s/mm2 provides ‘black blood’ images, which improves liver 
lesion detection and can be used as a substitute for T2WI (T2-weighted imaging). 
Intermediate and high b values (≥ 500 s/mm2) provide diffusion information used for 
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lesion characterization (60). We do not recommend the use of b value of zero for ADC 
quantification (except when IVIM is performed), in order to decrease  perfusion 
contamination. At least 2 or 3 b values (for example b<100, intermediate b value 400-
500, and higher b value between 500 to 1000) should be used for clinical purposes. 
More b values can be used for the purpose of IVIM.  
Liver lesion detection and characterization: DWI is considered to be more sensitive than 
FSE T2WI for liver lesion detection (61). The combination of DWI and CE (contrast-
enhanced)-T1WI is most sensitive for detection of malignant liver lesions, including liver 
metastases (Fig. 3) or HCC (Fig. 4). A recent meta-analysis showed no major 
difference between DWI and CE-T1WI using either extra-cellular or liver specific 
gadolinium based contrast agents for the detection of liver metastases (62). DWI 
demonstrates variable sensitivity for HCC detection; and the combination of DWI with 
contrast ag nts yields the best sensitivity for HCC detection. ADC quantification can be 
used to characterize liver lesions as cystic/necrotic or solid (Fig. 5). However, ADC 
alone is deemed insufficient for liver lesion characterization (61).  
Diagnosis of liver fibrosis and cirrhosis: There is data suggesting lower ADC in cirrhosis 
compared to non cirrhotic liver, and a negative correlation between liver ADC and the 
stage of liver fibrosis (63). It has been observed that the diagnostic performance of ADC 
is lower than that of liver stiffness measured with MR elastography (64). There is 
encouraging data on the use of IVIM for diagnosing fibrosis and cirrhosis (38), however 
comparison with other techniques such as elastography is needed (65).  
Liver tumor response: ADC has potential value in the evaluation of liver tumor response, 
with changes in ADC preceding changes in lesion size. Pre-treatment ADC may be 
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used to predict response to treatment. More prospective data is needed to determine 
the value of ADC in predicting clinical outcomes (59).   
 
5.2. Pancreas DWI  
MRI has high contrast resolution to detect the majority of pancreatic diseases through 
changes in T1/T2 relaxation and T1 contrast enhancement. However these changes 
might be insufficient to detect or characterize lesions that are of small size or occur in a 
background of chronic or acute inflammation. DWI provides another image contrast 
mechanism that may increase the sensitivity and the specificity of MRI of the pancreas 
(66). Different approaches might be used for detection and characterization of 
pancreatic lesions: 
• Use of a single low b-value (<100 s/mm2) instead of fat suppressed FSE T2WI to 
create black blood contrast. This is mainly used for detection of focal pancreatic 
lesions and focal liver lesions. 
• Use of 3 b-values (for example 0, 150, and 1000 s/mm2) to detect focal 
pancreatic lesions, examine signal changes, and extract ADC to improve 
characterization.  
• Use of a larger range of b values (typically 9-11 b values ranging from 0 to 1000 
s/mm2) in selected patients (because of large penalty in acquisition time) to improve 
the discrimination between focal pancreatitis and pancreatic adenocarcinoma by 
quantifying IVIM parameters. 
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Pancreatitis: There is lack of robust data about the role of DWI in pancreatic 
inflammation. It has been suggested that acute pancreatitis is associated with impeded 
diffusion and lower ADC compared to normal parenchyma (66). Recent studies suggest 
that DWI used in conjunction with T2WI and MRCP could be powerful for the 
assessment of acute pancreatitis (67), and that DWI may be useful in detecting infection 
in pancreatic fluid collections (68). DWI can also be used to detect focal lesions in 
autoimmune pancreatitis.  
Pancreatic adenocarcinoma: The addition of DWI to conventional MRI helps increasing 
the sensitivity of MRI for the detection of small pancreatic adenocarcinomas (69). PF/f 
extracted from the IVIM technique has a promising role for differentiation of pancreatic 
adenocarcinoma from mass-forming pancreatitis (70). However this strategy is not easy 
to implement in the clinic because of the long acquisition time and post-processing 
challenges.  
Pancreatic neuroendocrine tumors (Fig. 6): A recent small series comparing MRI to 
FDG-PET-CT for detection of pancreatic neuroendocrine tumors showed improved 
detection when adding DWI to T2WI; while (68)Ga-DOTATATE PET-CT was more 
sensitive than MRI for tumor detection (71). A significant negative correlation has been 
reported between ADC and tumor differentiation (72). DWI has also been reported as 
the most sensitive MRI sequence for the detection of liver metastases of 
neuroendocrine tumors (73).  
Pancreatic cystic lesions: DWI cannot be recommended for characterization of 
pancreatic cystic lesions, given the conflicting data (66).  
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In summary, DWI improves the sensitivity of MRI of the pancreas for the 
detection of focal solid lesions. Quantitative diffusion parameters are promising for the 
differential diagnosis of focal parenchymal solid lesions. The role of DWI in assessing 
complications of pancreatitis should be further investigated.  
 
5.3. Renal DWI  
The kidney is a particularly interesting organ to assess by DWI because of its high blood 
flow and water transport functions (74). DWI acquisition can be performed in the axial or 
coronal plane, using FB or RT acquisition.  
Characterization of renal lesions: A previous study compared the performance of CE-
T1WI and DWI when differentiating between benign cystic lesions, papillary and 
nonpapillary renal cell carcinomas (RCC) (Fig. 7), angiomyolipomas, and oncocytomas 
(75). It was found that DWI (AUC: 0.856; sensitivity: 86%; specificity: 80%) represents a 
reasonable, albeit less accurate, alternative to CE-MRI (AUC: 0.944; sensitivity: 100%; 
specificity: 89%) when characterizing renal masses. The diagnostic use of DWI is 
particularly relevant for patients with contraindications to gadolinium-based contrast 
agents (at risk for nephrogenic systemic fibrosis). However, DWI may generally provide 
additional information to radiologists: the same study showed that the combined use of 
DWI and CE-MRI led to an increased specificity of 96% compared to a specificity of 
89% for CE-MRI alone. A retrospective study in 83 patients focused on the use of ADC 
measurements to differentiate between subtypes of RCC (76). Interestingly, mean ADC 
values were computed for each lesion based on b values of 0 and 500 and of 0 and 800 
s/mm2. It was found that clear cell RCC was associated with significantly higher ADC 
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values compared with papillary and chromophobic RCC for both sets of b values (P 
<0.001). However, using b values of 0 and 800 sec/mm2 was more effective for 
distinguishing clear cell RCC from non-clear cell RCC (AUC: 0.973; sensitivity: 96%; 
specificity: 94%). It also led to significant differences in ADC values being found 
between papillary and chromophobic RCC (P<0.001), while this was not the case for b 
values of 0 and 500 sec/mm2. This study indicates that results may not be reproducible 
if different combinations of b values are used.  
Diffuse renal diseases: Diffuse renal diseases can be detected by morphological 
analysis only at advanced stages, which often leads to a delay in adequate treatment. 
DWI has shown promising results for the evaluation of acute and chronic renal failure 
with decreased ADC values reported in this group of patients compared to healthy 
volunteers. A recent prospective study in 71 patients with chronic kidney disease 
determined that ADC values were negatively correlated with pathology scores and 
significantly different among three groups of patients with different degrees or renal 
impairment (P <0.001) (77). The feasibility and reproducibility of DWI in transplanted 
kidneys have already been demonstrated (78) and initial results seem to be promising 
for the assessment of allograft deterioration (79). A recent study in 137 healthy 
participants concluded that ADC values in the kidney may also be age- and gender-
dependent (80). These findings suggest the need for greater standardization in DWI and 
for large studies in which differences in ADC measurements are analyzed by age group 
and gender. 
In summary, although morphological MRI and CT are excellent imaging 
modalities in the diagnostic work-up of a vast variety of renal pathologies, DWI shows 
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promising results as a noninvasive and sensitive technique to provide information 
beyond morphology.  
 
5.4. Prostate DWI 
DWI substantially improves localization of dominant tumors in the prostate and has 
served as an essential factor in the greatly expanded role of MRI in clinical 
management of prostate cancer over the last decade. DWI exhibits high sensitivity for 
high grade tumor, yet low sensitivity for low grade tumor (81), thereby helping to select 
patients with aggressive tumor for treatment while reducing overdiagnosis. ADC values 
obtained from DWI are inversely correlated with Gleason score (82) and are associated 
with tumor progression while on active surveillance (83) as well as with relapse 
following radiation or radical prostatectomy (84). 
 Historically, prostate DWI was acquired using a maximal b-value of 700-1,000 
sec/mm2.  Unsuppressed signal of benign prostate tissue within this b-value range 
obscures increased signal in tumors. However, improvements in scanner and sequence 
technology have facilitated acquisition at even higher b-values of 1,400-2,000 sec/mm2 
(85).  These “ultra” high b-values achieve greater suppression of benign prostate tissue, 
providing improved tumor conspicuity and localization (85). A particular role of ultra high 
b-value images is to help differentiate benign prostatic hyperplasia from transition zone 
tumors (85). In addition, the ultra high b-value images can be synthesized from images 
obtained using standard b-values rather than directly acquired (Fig. 8). This process 
entails no additional acquisition time in comparison with that required for acquisition of 
the standard b-value images and is useful if encountering excessive artifact or 
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insufficient SNR when directly acquiring ultra high b-value images. However, it should 
be noted that synthesized high b-value images are only extrapolations of low b-value 
behavior which may provide contrast variation relative to surrounding tissue but no 
additional quantification or representation of true high b-value behavior (e.g. kurtosis 
effects). Thus their use should be applied carefully and qualitatively. 
 The MRI Prostate Imaging and Reporting Data System (PI-RADS) version 2 
seeks to standardize prostate MRI interpretations (86). In this system, the criteria for 
assigning a 1-5 suspicion score on DWI reflect a composite assessment of both the 
ADC map and ultra high b-value images (whether acquired or synthesized). A 
peripheral zone lesion’s score on DWI serves as the dominant score in determining its 
overall suspicion category. However, in the transition zone, T2WI is the dominant 
sequence and determines the overall score in most instances. 
 Prostate DWI is prone to anatomic distortion and susceptibility-related artifact 
given the EPI acquisition. Rectal gas is a key factor in exacerbating such issues, 
particularly during non-endorectal coil imaging. A number of interventions may help 
reduce this artifact, including use of laxatives or enema, instruction to evacuate prior to 
imaging, and use of a suction catheter at the start of the examination to remove any 
rectal gas that remains despite these interventions. 
 
5.5. Breast DWI 
Technical considerations for breast DWI include optimizing acquisition protocols to 
achieve good image quality and appropriate b-value selection. EPI-based DWI 
sequences are susceptible to image distortions and ghosting artifacts, which are 
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particularly problematic for breast imaging due to off-center imaging, air-tissue 
interfaces, and high fat content in the breast. To reduce artifacts and optimize data 
quality, good shimming and suppression of lipid signal are essential. Advanced RF coil 
design, parallel imaging, and higher order shimming techniques help to overcome some 
of the unique challenges of breast DWI, particularly at higher field strengths. Currently, 
spatial distortion and lower resolution prevent direct correlation and one-to-one mapping 
of DCE-MRI and DWI features and limit clinical implementation of breast DWI, although 
a variety of new DWI acquisition strategies are under development to address these 
issues. 
The choice of b values directly affects SNR and quantitative ADC analysis, and 
may vary according to the application. For lesion conspicuity and detection purposes, a 
high maximum b-value (≥800 s/mm2) may be preferred (87), while for differentiation 
between benign and malignant lesions, choice of b-value may be less important (87, 
88). DWI acquisition using multiple b values provides a more accurate sampling of 
signal decay for calculation of ADC, and use of a nonzero minimum b value reference 
image can help eliminate contaminations from perfusion and flow. However, studies 
investigating these approaches have not clearly demonstrated a clinical diagnostic 
advantage in breast imaging (88). Given the time constraints of clinical practice, ADC 
calculation using two b-values (e.g. b = 0, 800 s/mm2) may be acceptable.  
Breast lesion detection and characterization: Breast malignancies demonstrate 
restricted diffusion, with high signal intensity on DWI and low ADC values, attributed to 
increased cellularity and decreased extracellular space (Fig. 9). The most widely 
explored application of DWI for breast imaging has been as an adjunct MRI technique to 
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reduce false positives and unnecessary biopsies associated with DCE-MRI. Numerous 
groups have demonstrated significant differences in ADC values of benign and 
malignant lesions and shown that ADC measures can improve diagnostic accuracy of 
conventional DCE-MRI (89). DWI may also offer a viable non-contrast method of breast 
MR screening without the costs and toxicity associated with DCE-MRI. Many 
mammographically and clinically occult breast cancers detected by DCE-MRI are also 
visible on DWI. In one study of asymptomatic women, DWI provided higher accuracy 
than screening mammography for the detection of breast malignancies (90).  
Treatment monitoring: Cytotoxic effects of neoadjuvant chemotherapy cause significant 
alterations in cell membrane integrity and reduced tumor cellularity, resulting in an 
increase in water mobility within the damaged tumor tissue. Increases in breast tumor 
ADC in response to treatment are detectable earlier than changes in tumor size on MRI, 
suggesting ADC may be a valuable early indicator of treatment efficacy (91). While a 
number of studies have shown promising associations of breast tumor ADC measures 
with outcomes to therapy, reports in the literature have been varied and more work is 
needed to validate DWI as a useful biomarker of treatment response in breast cancer.  
 
5.6. DWI in gynecological disease 
DWI should be corroborated with standard imaging sequences for the assessment of 
gynecological malignancies. A sagittal acquisition plane is suggested for assessing 
endometrial and cervical cancer, while axial acquisition is suggested for evaluating 
adnexal/ovarian pathology and for lymph node detection.  
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Myometrial tumor characterization: The differentiation between benign and malignant 
myometrial tumors on non-enhanced and post-contrast standard MRI sequences may 
be difficult with an overall accuracy of approximately 69%. A recent study has 
demonstrated the added value of DWI to improve characterization (92). In our 
experience, when a myometrial tumor displays a low T2 signal and/or a low DW signal, 
the tumor is always benign. If the tumor displays high or intermediate T2 signal and high 
DW signal, ADC map help differentiate benign from malignant tumors (93).  
Endometrial cancer (Fig. 10): Staging of endometrial cancer requires assessment of the 
depth of myometrial invasion, which strongly correlates with lymph node metastases. It 
has been shown that a fused T2 and axial oblique DWI perpendicular to the long axis of 
the myometrium is more accurate for assessment of myometrial invasion in comparison 
with T2WI or DCE-MRI (94). Moreover, DWI is helpful for detection of peritoneal 
implants.  
Cervical cancer: DWI is useful for detection of tumors not apparent on T2WI particularly 
in young patients with a diffusely infiltrating adenocarcinoma. In addition, DWI is a more 
sensitive technique than T2WI for detection of small residual tumor after chemoradiation 
therapy before surgery (95). Finally, DWI is useful after the end of therapy, to 
differentiate tumor recurrence from fibrosis (95). 
Ovarian pathology: Several groups have investigated the ability of DWI for 
characterization of ovarian tumors. In our experience, both malignant and benign 
tumors may display high residual signal on high b value images (e.g., b1000), while the 
absence of high b1000 signal is highly predictive of benignancy (96). On the other hand, 
a tumor displaying both low T2 and low DWI signal is generally benign. The addition of 
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DWI to conventional sequences increases the diagnostic confidence in 15% of cases 
(97). A second application of DWI has been in the assessment of peritoneal spread of 
gynecological malignancy with better contrast than on CT or conventional MRI. Finally, 
DWI may be useful to evaluate the early response to neoadjuvant chemotherapy in 
ovarian cancer with an increase in ADC after the first cycle of treatment (98). 
 
5.7. Spine DWI 
The vertebral bone marrow is composed of three main elements: fatty marrow, 
hematopoietic marrow and trabecular bone. The special tissue properties of the bone 
marrow and the complex anatomy of the spine, result in differences in magnetic 
susceptibility which complicate MRI specially EPI techniques. However, with advances 
in EPI techniques, such as improved gradient systems, parallel imaging and dynamic 
shimming; sagittal SS EPI has become a fairly robust tool (99). Other DW pulse 
sequences such as segmented EPI techniques and SS FSE sequences are possible 
alternatives. A precise ADC measurement can still be difficult and large variations are 
found in the literature, mainly explained by acquisition parameter differences (99).  
DWI is a powerful addition to the arsenal of MRI techniques for the detection of bone 
marrow tumor dissemination, improving sensitivity for detecting bone metastases in a 
variety of tumor types (100) (Fig. 11). DWI increases confidence in monitoring treatment 
response and assisting in the differentiation of treatment related changes from tumor, 
therefore has become an important component of whole body MRI oncology protocols 
(Fig. 12).   
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Distinguishing between benign and malignant etiologies of vertebral fractures with MRI 
is problematic, particularly if only one vertebra is affected. The value of DWI in 
discriminating between osteoporotic and metastatic vertebral fractures is controversial 
and insufficiently reliable (101, 102).  
DWI is useful in differentiating degenerative and infectious endplate abnormalities. 
Symptomatic degenerative vertebral endplate signal changes (Modic type 1) can be 
difficult to differentiate from acute spondylodiscitis using conventional MRI techniques. 
Recently a characteristic DWI finding of well-marginated, linear, typically paired regions 
of high signal at the interface of normal with abnormal marrow, referred to as a ‘claw’ 
sign, has been shown to be highly suggestive of degeneration and its absence in cases 
with Modic type I changes strongly suggestive of diskitis/osteomyelitis (103). 
 
5.8 Oncologic treatment response and whole body DWI 
The assessment of tumor response to oncologic treatment is still largely based on size 
measurement criteria or modification of these (104). However, with the growing use of 
cytostatic treatments, tumor size measurements are becoming insensitive to efficacy 
effects and there is a need for new imaging biomarkers to assess treatment 
effectiveness. DWI can determine the success of treatments through alternations in 
tumor size/volume, signal intensity and ADC changes. Numerous studies have shown 
that ADC values in a number of tumor types (including brain, lung, liver metastases, 
HCC, pancreas, kidneys, cervix, uterine, prostate, lymphoma, sarcoma and primary and 
secondary bone malignancies) increases with effective treatments, which include 
chemotherapy, radiotherapy, novel targeted treatments, embolization and 
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radiofrequency ablation. ADC increases often precedes reductions in tumor size, and 
can may be observed as early as 1-4 weeks of initiating treatment (105). However, the 
magnitude and temporal evolution of ADC change depends on the mechanism of action 
of the treatment, with those resulting in profound cell kill resulting in the most rapid and 
largest increases in the ADC values.  
A major strength of ADC measurements in the body is its measurement repeatability. In 
well-conducted studies, using free-breathing techniques, the test-retest repeatability of 
ADC measurements in single-center and cross-center studies have shown to be good. 
Bland-Altman analyses show that the coefficient of repeatability is typically about 15-
30% across multiple studies. More recently, the relatively robust nature of ADC 
measurements was shown within and between vendors, for machines operating at both 
1.5T and 3.0T (106). The inter-vendor repeatability was also shown to in one study to 
be about 14% (106). However, the measurement repeatability of quantitative DWI 
indices derived using more complex diffusion models (e.g. IVIM and DKI) can be poor, 
and it is important to apply complex models judiciously, considering aspects of image 
signal-to-noise, disease type and treatment contexts.  
A key unmet clinical need is for a robust biomarker to assess the treatment 
effectiveness of bone metastases, especially for prostate and breast cancers (107). This 
is because radionuclide bone scans do not directly identify metastases (bone scan 
uptake is a marker of osteoblastic activity) and there are no accepted bone scan criteria 
for defining therapy benefit. As a result, patients are treated to documented progression 
(defined clinically and with imaging), often resulting in unrecognized tumor burdens and 
delays before treatment changes are instituted. This need can potentially be met by 
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whole body MRI methods. Whole body DWI is technically feasible across vendor 
systems and can be undertaken at both 1.5T and 3.0T (Fig. 12). Visual assessments of 
the inverted-grey scale maximum intensity projection images can be used to appraise 
treatment effects; with treatment response showing reductions in high b-value signal 
intensity (Fig. 13). In addition, the DWI signal intensity of bone metastases can be used 
for disease volume segmentation and global ADC quantification (108). Effective 
treatments are associated with reductions in disease volume accompanying rises in the 
ADC values. Importantly, whole body imaging enables heterogeneity of response to be 
documented (commonly seen in the metastatic setting after several lines of treatments). 
However, the criteria for defining bone metastasis response, stable disease and disease 
progression using DWI are being established. It is likely that this would require a 
combination of imaging criteria, which may include changes in bone marrow fat fraction, 
signal intensity changes on conventional T1 and T2WI, as well as DWI signal and ADC 
measurement characteristics (107). 
 
6. Future directions 
6.1. IVIM DWI: Potential body imaging applications  
There is considerable recent literature on the use of IVIM, which employs a bi-
exponential diffusion model to estimate capillary contributions to the DW signal (40, 42, 
109). IVIM has the potential to help characterize diffuse liver disease (37, 38), focal liver 
and pancreatic lesions (110, 111) and renal function (112) (Fig. 2). IVIM is increasingly 
applied in a wide variety of cancer types, due to their typically hypervascular and 
hypercellular features (32, 110, 113). Data showing superiority of IVIM parameters over 
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ADC for tissue characterization is limited, and more evidence is needed. IVIM 
parameter reproducibility and the role of IVIM parameters in treatment response need 
also to be better defined. In addition, the biological significance of IVIM related 
“perfusion” needs to be better understood. 
 
6.2. Diffusion kurtosis imaging (DKI) 
While diffusion data is most commonly processed using a standard mono-exponential fit 
to obtain the parameter ADC, this model may not in fact optimally fit the raw diffusion 
data. Other more sophisticated models have been investigated, including the bi-
exponential and stretched exponential diffusion models, in efforts to obtain more reliable 
estimates of tissue diffusivity. However, these models do not reflect the non-Gaussian 
(non “free”) behavior of water diffusion that manifests at ultra high b-values and is 
believed to provide additional insights into tissue architecture (114). Recent publications 
employing higher b-values have shown advantages in using DKI, a model of diffusion 
that characterizes the excess kurtosis from non-Gaussian diffusion propagators in 
breast, prostate and pancreatic studies (115, 116). While largely applied for brain 
imaging, DKI has more recently been investigated in body imaging. The primary such 
application has been in the prostate, in which greater performance for differentiating low 
and high grade prostate cancer using K than standard ADC obtained from a mono-
exponential fit has been observed (117). DKI has also been preliminarily explored for 
tumor characterization in the breast as well as the head and neck. While hardware 
improvements have allowed for better quality of DWI performed at very high b-values of 
approximately 2,000 s/mm2 and thereby facilitated the clinical application of DKI in 
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recent years, great attention to acquisition detail is important to ensure sufficient SNR at 
the maximal b-values and thus reliability of the computed metrics. In addition, the exact 
microstructural property of tissue represented by Kapp , like the ADC, depends on the 
tissue architecture studied; higher specificity is therefore expected when DKI is 
combined with a biophysical model. 
 
6.3. DWI and PET/MRI 
PET/MRI is a novel hybrid imaging modality, combining the morphological, functional 
and molecular imaging potential of MRI and PET. The combination with DWI is an 
excellent example for the true potential of PET/MR, as it allows for insights into tissue 
structure and biology, which are not possible with PET/CT (118). There are generally 
two different strategies of combining DWI and PET in PET/MR. One can use the 
excellent s nsitivity of DWI for lesion detection and combine it with PET. However, for 
whole-body imaging, adding DWI to a PET/MR protocol might be quite time-consuming, 
unless a very brief DWI protocol is employed. This only makes sense, when one 
expects truly synergistic information. It has been suggested that combining two 
excellent staging modalities may not always provide complementary but rather 
redundant information.  
A classic example would be primary staging in an FDG-avid malignancy where usually 
FDG is sufficient for tumor detection and DWI adds little information (119). However the 
situation is different when PET is used to gather biological information with specific 
tracers, like FLT (fluorothymidine)-PET for assessment of tumor proliferation or receptor 
imaging. In these cases lesions might be negative in PET but could still be picked up 
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with whole body DWI, thus synergistically combining lesion detection and 
characterization. More practical and less time consuming for PET/MR in oncology is 
region-specific DWI. This means that DWI is only added to the MR protocol for a 
specific area of interest, where PET might be limited for lesion detection, like in the liver 
to rule out small liver metastases. However, the true potential of combining DWI and 
PET in PET/MR lies not so much in lesion detection as described above, but to make 
maximum use of the quantitative information on tissue biology one gets in a single 
examination with optimum image coregistration. By analyzing the data on restricted 
water movement and tracer uptake on a voxel-by-voxel basis, a novel set of biomarkers 
might evolve, which add synergistic information on tumor biology to the classical 
biomarkers derived from tissue biopsy or liquid biopsy (120). Compared to the latter, 
PET/MR derived biomarkers have several advantages like being minimally invasive, 
allowing for serial whole-body assessment and depicting intra- and inter-lesional 
heterogeneity. This method could be helpful for biopsy guidance, prognostic 
assessment, radiation therapy planning or response evaluation (Fig. 14). 
 
Conclusion 
The 2015 ISMRM sponsored workshop has stimulated in depth discussions of body 
DWI and the current state of the art. The key points are summarized below: 
• Body DWI is no longer direct transportation of methods from the brain but an 
adaptation to specific challenges and opportunities of extracranial anatomies and 
pathologies.  
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• Validated quality control metrics are available to quantify measurement 
repeatability, reproducibility and precision of quantitative DWI. ADC 
measurements outside the brain show good to excellent measurement 
repeatability, although more data on inter-platform reproducibility is needed.  
• Perfusion insensitive ADC (e.g. obtained from b-values between 50 and 1000 
s/mm2) is robust and can be recommended for general evaluation.  
• DWI has been shown to improve disease assessment in the liver, pancreas, 
kidneys, prostate, breast, gynecological diseases and spine. 
• DWI (including whole body DWI) shows substantial promise for assessing tumor 
response in oncology, although larger prospective studies are needed to qualify 
ADC as a response biomarker.  
• Under appropriate measurement conditions, non-monoexponential diffusion models 
(e.g. IVIM, DKI and stretched exponential) could be explored to provide further 
tissue characterization, particularly in oncological applications.  
• Further exploration of non-monoexponential diffusion models and combination with 
PET imaging would further enhance the value of DWI in the body.  
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Free-breathing or respiratory-triggered (for abdominal applications) 
fat-suppressed single-shot echoplanar imaging 
TR ≥ 3000 ms 
TE Shortest possible (≤90 ms) 
Matrix At least 128x128 (higher for prostate) 




Number of b-values At least 2 b-values needed; one or two additional intermediate b-
values may be obtained, particularly if performing quantitative ADC 
measurements  
Minimum b-value <100 s/mm2 
Maximum b-value 800-1000 s/mm2; further ultra high b-values in range of 1,400-2,000 
sec/mm2 may be acquired or computed and are routinely advised in 
the prostate 
Number of directions Three directions 
SNR considerations Ensure adequate number of averages and acquisition time to 
provide sufficient SNR on maximal b-value images 
Acquisition plane  Axial (abdomen), axial oblique (prostate), coronal (kidneys), sagittal 
(female pelvis) 
Post-processing Inline generation of ADC map using standard mono-exponential fit 
is appropriate for routine clinical applications  
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Figure Legends 
 
Fig. 1: 68 year-old male with high serum prostate specific antigen (20 ng/mL) and 
multiple prior negative prostate biopsies. Reduced FOV DWI at 3.0T (using FOV 24 cm, 
TR 4000/TE 65, slice thickness 3 mm, 160x80) at b1600 demonstrates hyperintense left 
apex tumor (arrows) with low ADC, and hypervascularity on DCE-MRI. The lesion is 
isointense on T2-weighted imaging. The lesion was confirmed to be prostate cancer 
(Gleason 4+3) on targeted ultrasound-guided prostate biopsy.  
 
Fig. 2: IVIM DWI performed in a 24-year old male volunteer. Coronal DWI performed 
over the abdomen using 7 b-values (0, 25, 50, 100, 200, 400 and 800 s/mm2) at 1.5T. 
Diffusion coefficient (D), pseudo diffusion coefficient (D*) and perfusion fraction (f) maps 
are shown. Note high quality parametric maps of D and f, while D* map is highly 
variable. Typical signal attenuation curves of voxel data fitting in the liver and kidneys 
are shown in the lower row, demonstrating biexponential behavior. IVIM DWI 
measurements can be made with greater confidence where there is excellent image 
signal-to-noise and in tissues with significant vascular perfusion, as is the case in the 
liver and kidneys and in many (but not all) types of cancer. 
 
Fig. 3: 51 year-old female with metastatic colon cancer. DW image at b 800 
demonstrates an infiltrative tumor (long arrow) in the right hepatic lobe with hyperintense 
peripheral and hypointense central components, corresponding to low/high ADC (central 
necrosis and solid peripheral components). There are additional smaller metastatic 
lesions in the left hepatic lobe with restricted diffusion (short arrows).    
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Fig. 4: 69 year-old male with liver cirrhosis secondary to chronic hepatitis C and 
hepatocellular carcinoma (HCC) with portal vein invasion. DW images at b50 and b500 
demonstrate right posterior lobe HCC with restricted diffusion (short arrow) with 
evidence of tumor thrombus involving the right posterior portal vein (long arrow), better 
depicted on DWI compared to contrast-enhanced T1-weighted images at the arterial and 
portal venous phases (AP and PVP). 
 
Fig. 5: 60 year-old male with metastatic gastrointestinal stromal tumor. DW images/ADC 
map demonstrate two large lesions: an intrahepatic lesion (arrow) is mildly hyperintense 
at b 50 and strongly hyperintense at b 1000 with low ADC (restricted diffusion) 
compatible with viable tumor. The extrahepatic lesion (asterisk) is strongly hyperintense 
at b 50, hypointense at b 1000, with high ADC, compatible with necrotic/cystic 
metastatic lesion. Post-contrast T1-weighted image confirms DWI findings.     
 
Fig. 6: 60 year-old male with small pancreatic neuroendocrine tumor, better depicted on 
high b value DWI and fused DWI-T2 images (arrow). The lesion is not visible on T2 
HASTE image.  
 
Fig. 7: 60 year-old male with papillary renal cell carcinoma. Standard imaging 
sequences demonstrate a left renal T2 hypointense lesion/T1 hyperintense lesion with 
evidence of enhancement on subtracted image. The lesion demonstrates restricted 
diffusion, with high signal on b1000 and on calculated b1600, with low mean ADC 
(approximately 0.8 x 10-3 mm2/s).    
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Fig. 8: 55 year-old male with prostate cancer (Gleason score 3+4). Left midgland 
transition zone tumor (arrow) appearing hypointense on T2WI with low ADC. The tumor 
is hyperintense on diffusion images, and more conspicuous on calculated b1500 than on 
acquired b1000 diffusion image, due to incomplete suppression of background benign 
prostate tissue on b1000 image.  
 
Fig. 9: 31-year old female with Li-Fraumeni syndrome undergoing breast MRI 
screening. DCE-MRI demonstrates a mammographically occult mass at 3 o’clock in the 
right breast (arrow), measuring 11 mm with smooth margins and internal septations, 
rapid enhancement and washout, assessed as BI-RADS category 4. The lesion exhibits 
restricted diffusion on DWI, with bright signal compared to adjacent parenchyma on b 
800 s/mm2 (arrow) and low ADC of 1.15 x10-3 mm2/s. Ultrasound-guided biopsy 
revealed malignant phyllodes tumor. 
 
Fig. 10: 70 year-old female with endometrial carcinoma without myometrial infiltration 
(Stage IA). Comparison of axial oblique T2WI (a), DWI (b) and fused T2 and DWI (c). 
The contrast between the tumor and the myometrium is higher with DWI than with T2WI 
with better appreciation of the margins on the fused T2-DWI image. 
 
Fig. 11: 59 year-old male with lung cancer and metastatic vertebral lesions. Lesions 
demonstrate high intensity and high conspicuity on high b value DWI (b1000, arrows) 
(A) and appear hypointense on T1WI (B), minimally enhancing on T1 post-contrast  (C), 
and moderately hyperintense on T2 WI (D).  
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Fig. 12: 60 year-old male with multiple myeloma. Coronal reformatted whole-body DWI 
image with inverted greyscale contrast for b=800 s/mm2 demonstrates diffuse tumor 
burden in low signal in the bone marrow.  
 
Fig. 13: 65 year-old female with metastatic bone disease from breast cancer. Top row: 
Pre and post-treatment inverted greyscale maximum intensity projection b=900 s/mm2 
images. Disease segmentation (colored red) allows quantification of total disease 
volume (tDV) before and after treatment. Note reduction in disease volume after 
chemotherapy. Bottom image: ADC histograms associated with disease volumes pre 
and post-treatment shows more than 50% increase in median ADC values after 
treatment, in keeping with treatment response.  
 
Fig. 14: Multimodal multiparametric imaging using Anima M3P (by S. G. Nekolla and S. 
van Marwick; image courtesy: M. Eiber, D. Vriens). [11C]choline PET/MRI in prostate 
cancer. By creating a scatter plot of the correlation of SUV (y-axis) and ADC (x-axis), 
one can define 9 different areas (“Likelihood” plot). The most suspicious areas for 
malignancy are coded in red/orange (highest SUV and lowest ADC). The “Quotient” plot 
is a map of SUV divided by ADC. The areas with the brightest signal are the most 
suspicious ones. A biopsy could be targeted to areas with the highest likelihood of 
malignancy / potentially most aggressive tumor parts.  
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Figures  
Fig. 1: 68 year-old male with high serum prostate specific antigen (20 ng/mL) and 
multiple prior negative prostate biopsies. Reduced FOV DWI at 3.0T (using FOV 24 cm, 
TR 4000/TE 65, slice thickness 3 mm, 160x80) at b1600 demonstrates hyperintense left 
apex tumor (arrows) with low ADC, and hypervascularity on DCE-MRI. The lesion is 
isointense on T2-weighted imaging. The lesion was confirmed to be prostate cancer 
(Gleason 4+3) on targeted ultrasound-guided prostate biopsy.  
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Fig. 2: IVIM DWI performed in a 24-year old male volunteer. Coronal DWI performed 
over the abdomen using 7 b-values (0, 25, 50, 100, 200, 400 and 800 s/mm2) at 1.5T. 
Diffusion coefficient (D), pseudo diffusion coefficient (D*) and perfusion fraction (f) maps 
are shown. Note high quality parametric maps of D and f, while D* map is highly 
variable. Typical signal attenuation curves of voxel data fitting in the liver and kidneys 
are shown in the lower row, demonstrating biexponential behavior. IVIM DWI 
measurements can be made with greater confidence where there is excellent image 
signal-to-noise and in tissues with significant vascular perfusion, as is the case in the 
liver and kidneys and in many (but not all) types of cancer. 
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Fig. 3: 51 year-old female with metastatic colon cancer. DW image at b 800 
demonstrates an infiltrative tumor (long arrow) in the right hepatic lobe with 
hyperintense peripheral and hypointense central components, corresponding to 
low/high ADC (central necrosis and solid peripheral components). There are additional 
smaller metastatic lesions in the left hepatic lobe with restricted diffusion (short arrows).   
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Fig. 4: 69 year-old male with liver cirrhosis secondary to chronic hepatitis C and 
hepatocellular carcinoma (HCC) with portal vein invasion. DW images at b50 and b500 
demonstrate right posterior lobe HCC with restricted diffusion (short arrow) with 
evidence of tumor thrombus involving the right posterior portal vein (long arrow), better 
depicted on DWI compared to contrast-enhanced T1-weighted images at the arterial 
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Fig. 5: 60 year-old male with metastatic gastrointestinal stromal tumor. DW 
images/ADC map demonstrate two large lesions: an intrahepatic lesion (arrow) is mildly 
hyperintense at b 50 and strongly hyperintense at b 1000 with low ADC (restricted 
diffusion) compatible with viable tumor. The extrahepatic lesion (asterisk) is strongly 
hyperintense at b 50, hypointense at b 1000, with high ADC, compatible with 
necrotic/cystic metastatic lesion. Post-contrast T1-weighted image confirms DWI 
findings.    
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Page 56 of 64 
Fig. 6: 60 year-old male with small pancreatic neuroendocrine tumor, better depicted on 
high b value DWI and fused DWI-T2 images (arrow). The lesion is not visible on T2 
HASTE image.  
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Page 57 of 64 
Fig. 7: 60 year-old male with papillary renal cell carcinoma. Standard imaging 
sequences demonstrate a left renal T2 hypointense lesion/T1 hyperintense lesion with 
evidence of enhancement on subtracted image. The lesion demonstrates restricted 
diffusion, with high signal on b1000 and on calculated b1600, with low mean ADC 
(approximately 0.8 x 10-3 mm2/s).    
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Page 58 of 64 
Fig. 8: 55 year-old male with prostate cancer (Gleason score 3+4). Left midgland 
transition zone tumor (arrow) appearing hypointense on T2WI with low ADC. The tumor 
is hyperintense on diffusion images, and more conspicuous on calculated b1500 than 
on acquired b1000 diffusion image, due to incomplete suppression of background 
benign prostate tissue on b1000 image.  
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Page 59 of 64 
Fig. 9: 31-year old female with Li-Fraumeni syndrome undergoing breast MRI 
screening. DCE-MRI demonstrates a mammographically occult mass at 3 o’clock in the 
right breast (arrow), measuring 11 mm with smooth margins and internal septations, 
rapid enhancement and washout, assessed as BI-RADS category 4. The lesion exhibits 
restricted diffusion on DWI, with bright signal compared to adjacent parenchyma on b 
800 s/mm2 (arrow) and low ADC of 1.15 x10-3 mm2/s. Ultrasound-guided biopsy 
revealed malignant phyllodes tumor. 
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Page 60 of 64 
Fig. 10: 70 year-old female with endometrial carcinoma without myometrial infiltration 
(Stage IA). Comparison of axial oblique T2WI (a), DWI (b) and fused T2 and DWI (c). 
The contrast between the tumor and the myometrium is higher with DWI than with T2WI 
with better appreciation of the margins on the fused T2-DWI image.
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Page 61 of 64 
Fig. 11: 59 year-old male with lung cancer and metastatic vertebral lesions. Lesions 
demonstrate high intensity and high conspicuity on high b value DWI (b1000, arrows) 
(A) and appear hypointense on T1WI (B), minimally enhancing on T1 post-contrast  (C), 
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Page 62 of 64 
Fig. 12: 60 year-old male with multiple myeloma. Coronal reformatted whole-body DWI 
image with inverted greyscale contrast for b=800 s/mm2 demonstrates diffuse tumor 
burden in low signal in the bone marrow.  
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Page 63 of 64 
Fig. 13: 65 year-old female with metastatic bone disease from breast cancer. Top row: 
Pre and post-treatment inverted greyscale maximum intensity projection b=900 s/mm2 
images. Disease segmentation (colored red) allows quantification of total disease 
volume (tDV) before and after treatment. Note reduction in disease volume after 
chemotherapy. Bottom image: ADC histograms associated with disease volumes pre 
and post-treatment shows more than 50% increase in median ADC values after 
treatment, in keeping with treatment response.  
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Fig. 14: Multimodal multiparametric imaging using Anima M3P (by S. G. Nekolla and S. 
van Marwick; image courtesy: M. Eiber, D. Vriens). [11C]choline PET/MRI in prostate 
cancer. By creating a scatter plot of the correlation of SUV (y-axis) and ADC (x-axis), 
one can define 9 different areas (“Likelihood” plot). The most suspicious areas for 
malignancy are coded in red/orange (highest SUV and lowest ADC). The “Quotient” plot 
is a map of SUV divided by ADC. The areas with the brightest signal are the most 
suspicious ones. A biopsy could be targeted to areas with the highest likelihood of 
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Fig. 1: 68 year-old male with high serum prostate specific antigen (20 ng/mL) and multiple prior negative 
prostate biopsies. Reduced FOV DWI at 3.0T (using FOV 24 cm, TR 4000/TE 65, slice thickness 3 mm, 
160x80) at b1600 demonstrates hyperintense left apex tumor (arrows) with low ADC, and hypervascularity 
on DCE-MRI. The lesion is isointense on T2-weighted imaging. The lesion was confirmed to be prostate 
cancer (Gleason 4+3) on targeted ultrasound-guided prostate biopsy.  
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Fig. 2: IVIM DWI performed in a 24-year old male volunteer. Coronal DWI performed over the abdomen 
using 7 b-values (0, 25, 50, 100, 200, 400 and 800 s/mm2) at 1.5T. Diffusion coefficient (D), pseudo 
diffusion coefficient (D*) and perfusion fraction (f) maps are shown. Note high quality parametric maps of D 
and f, while D* map is noisy. Typical signal attenuation curves of voxel data fitting in the liver and kidneys 
are shown in the lower row, demonstrating biexponential behavior. IVIM DWI measurements can be made 
with greater confidence where there is excellent image signal-to-noise and in tissues with significant 
vascular perfusion, as is the case in the liver and kidneys.  
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Fig. 3: 51 year-old female with metastatic colon cancer. DW image at b 800 demonstrates an infiltrative 
tumor (long arrow) in the right hepatic lobe with hyperintense peripheral and hypointense central 
components, corresponding to low/high ADC (central necrosis and solid peripheral components). There are 
additional smaller metastatic lesions in the left hepatic lobe with restricted diffusion (short arrows).    
193x87mm (150 x 150 DPI)  
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Fig. 4: 69 year-old male with liver cirrhosis secondary to chronic hepatitis C and hepatocellular carcinoma 
(HCC) with portal vein invasion. DW images at b50 and b500 demonstrate right posterior lobe HCC with 
restricted diffusion (short arrow) with evidence of tumor thrombus involving the right posterior portal vein 
(long arrow), better depicted on DWI compared to contrast-enhanced T1-weighted images at the arterial 
and portal venous phases (AP and PVP).  
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Fig. 5: 60 year-old male with metastatic gastrointestinal stromal tumor. DW images/ADC map demonstrate 
two large lesions: an intrahepatic lesion (arrow) is mildly hyperintense at b 50 and strongly hyperintense at 
b 1000 with low ADC (restricted diffusion) compatible with viable tumor. The extrahepatic lesion (asterisk) is 
strongly hyperintense at b 50, hypointense at b 1000, with high ADC, compatible with necrotic/cystic 
metastatic lesion. Post-contrast T1-weighted image confirms DWI findings.      
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Fig. 6: 60 year-old male with small pancreatic neuroendocrine tumor, better depicted on high b value DWI 
and fused DWI-T2 images (arrow). The lesion is not visible on T2 HASTE image.  
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Fig. 7: 60 year-old male with papillary renal cell carcinoma. Standard imaging sequences demonstrate a left 
renal T2 hypointense lesion/T1 hyperintense lesion with evidence of enhancement on subtracted image. The 
lesion demonstrates restricted diffusion, with high signal on b1000 and on calculated b1600, with low mean 
ADC (approximately 0.8 x 10-3 mm2/s).    
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Fig. 8: 55 year-old male with prostate cancer (Gleason score 3+4). Left midgland transition zone tumor 
(arrow) appearing hypointense on T2WI with low ADC. The tumor is hyperintense on diffusion images, and 
more conspicuous on calculated b1500 than on acquired b1000 diffusion image, due to incomplete 
suppression of background benign prostate tissue on b1000 image.  
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Fig. 9: 31-year old female with Li-Fraumeni syndrome undergoing breast MRI screening. DCE-MRI 
demonstrates a mammographically occult mass at 3 o’clock in the right breast (arrow), measuring 11 mm 
with smooth margins and internal septations, rapid enhancement and washout, assessed as BI-RADS 
category 4. The lesion exhibits restricted diffusion on DWI, with bright signal compared to adjacent 
parenchyma on b 800 s/mm2 (arrow) and low ADC of 1.15 x10-3 mm2/s. Ultrasound-guided biopsy 
revealed malignant phyllodes tumor.  
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Fig. 10: 70 year-old female with endometrial carcinoma without myometrial infiltration (Stage IA). 
Comparison of axial oblique T2WI (a), DWI (b) and fused T2 and DWI (c). The contrast between the tumor 
and the myometrium is higher with DWI than with T2WI with better appreciation of the margins on the 
fused T2-DWI image.  
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Fig. 11: 59 year-old male with lung cancer and metastatic vertebral lesions. Lesions demonstrate high 
intensity and high conspicuity on high b value DWI (b1000, arrows) (A) and appear hypointense on T1WI 
(B), minimally enhancing on T1 post-contrast  (C), and moderately hyperintense on T2 WI (D).  
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Fig. 12: 60 year-old male with multiple myeloma. Coronal reformatted whole-body DWI image with inverted 
greyscale contrast for b=800 s/mm2 demonstrates diffuse tumor burden in low signal in the bone marrow.  
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Fig. 13: 65 year-old female with metastatic bone disease from breast cancer. Top row: Pre and post-
treatment inverted greyscale maximum intensity projection b=900 s/mm2 images. Disease segmentation 
(colored red) allows quantification of total disease volume (tDV) before and after treatment. Note reduction 
in disease volume after chemotherapy. Bottom image: ADC histograms associated with disease volumes pre 
and post-treatment shows more than 50% increase in median ADC values after treatment, in keeping with 
treatment response.  
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Fig. 14: Multimodal multiparametric imaging using Anima M3P (by S. G. Nekolla and S. van Marwick; image 
courtesy: M. Eiber, D. Vriens). [11C]choline PET/MRI in prostate cancer. By creating a scatter plot of the 
correlation of SUV (y-axis) and ADC (x-axis), one can define 9 different areas (“Likelihood” plot). The most 
suspicious areas for malignancy are coded in red/orange (highest SUV and lowest ADC). The “Quotient” plot 
is a map of SUV divided by ADC. The areas with the brightest signal are the most suspicious ones. A biopsy 
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